UNSPSC 85781409: Supplement left femoral region with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left femoral region with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0YU847Z

UNSPSC 85781409 Supplement left femoral region with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that bears no meaningful relationship to actual state and local procurement activity under this designation. The code nominally describes a specific orthopedic surgical procedure, yet the most recent state and local opportunities tagged with this code solicit occupational medical surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-out programs, and emergency medical services for detained youth — none of which involve femoral region supplementation or tissue substitute placement. State and local procurement offices appear to have mislabeled these opportunities, and the code itself generates no genuine contracting activity aligned with its clinical definition.

The sourced opportunities span Arizona (Phoenix Retirement Office), California (City of Long Beach and County of Santa Clara Health System), Florida (Collier County), Texas (Harris County Juvenile Probation Department), and Washington State (Department of Transportation), across cities, counties, and special-purpose health systems — a geographic and issuing-body mix that reflects general government medical and administrative contracting rather than a coherent product or service family. No representative recent solicitations substantively match the code's stated scope. This code shows little relevant recent activity in state and local procurement and warrants deprioritization in business development pipeline management.